A drug called ISRIB (integrated stress response inhibitor) restored the normal function of cells from a person with the rare disorder MEHMO syndrome, according to researchers at the National Institutes of Health and other institutions. Their study appears in Molecular Cell.
News
NICHD issues News Releases and Media Advisories to the news media. Spotlight and Research Feature articles explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement of relevant information, such as a notable staff change.
Item of Interest: NICHD Neuroscientist R. Douglas Fields Named AAAS Fellow
R. Douglas Fields, Ph.D., chief of NICHD’s section on Nervous System Development and Plasticity has been named a distinguished Fellow of the American Association for the Advancement of Science.
Item of Interest: Now Available: NIH Research Plan on Fragile X and Associated Conditions
The Trans-NIH Fragile X Coordinating Committee, led by NICHD, recently published the final NIH Strategic Research Plan on FMR1-Associated Conditions.
Item of Interest: Joint study finds safe infant sleep practices need improvement
A study from federal researchers shows that information about ways to reduce the risk of sleep-related infant deaths is not reaching all caregivers or healthcare providers.
Spotlight: Women in Science: Mary Dasso Balances Passion and Practicality in Research
NICHD researcher Mary Dasso, Ph.D., considers herself to have been lucky at many points in her
career. But luck alone cannot account for her success as a principal investigator and program leader. Read about her
career over the decades.
Release: Family, community bonds help decrease mental health problems of former child soldiers
Acceptance and support from communities and families appear to lessen the toll of mental health conditions experienced by former child soldiers transitioning to early adulthood, according to a study by researchers at the National Institutes of Health and other institutions.
Item of Interest: Focus on FMR1: NIH Invites Comments on its Research Plan on Fragile X and Associated Conditions
NIH invites scientists, advocacy and family groups, representatives from federal and local agencies, and others to provide comments and suggestions on its draft research plan on Fragile X syndrome and associated conditions.
Spotlight: How artificial intelligence and other new technologies are advancing healthcare
Scientists and engineers are pioneering new tools and methods to advance healthcare in revolutionary ways. Learn about emerging technologies funded by NICHD.
Spotlight: Maternal Health Research Advances
NICHD was established more than 50 years ago to help understand maternal health and improve pregnancy outcomes. These selected advances highlight NICHD’s contributions to advancing the health and well-being of pregnant women, mothers, and families everywhere.
Item of Interest: Interested in Medical Rehabilitation? NIH Wants to Hear from You
NIH invites comments on its Plan of Rehabilitation Research to help update the plan.
Spotlight: Harnessing light to study human development and the brain
NICHD’s Amir Gandjbakhche, Ph.D., leads a team that is pioneering the use of portable imaging technology to study human development and health conditions, including brain injuries and disorders.
Science Update: Delayed cord clamping may benefit infant brain development, NIH-funded study finds
A 5-minute delay in clamping the umbilical cord after birth may benefit an infant’s developing brain, suggests a small study funded by the National Institutes of Health. By 4 months of age, the brains of infants in the study who underwent delayed clamping had more myelin, a brain-insulating material, compared to those whose cords were clamped within 20 seconds.
Spotlight: Women in Science: Reflecting on Five Decades of Research with Keiko Ozato
Seventy-seven year old NICHD researcher Keiko Ozato, Ph.D., started her laboratory in 1981. We caught up with her as she thought about how some early challenges shaped her life and research career.
Media Advisory: NICHD chronicles its major research advances of 2018
As 2018 winds down, a new slideshow highlights a selection of initiatives, therapies, and scientific advances supported by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Spotlight: Selected NICHD Research Advances of 2018
In 2018, researchers funded by NICHD made significant progress in advancing the health and well-being of infants, children, teenagers, and adults across the United States and around the world.
Item of Interest: NICHD seeks applications to study effects of maternal opioid use on newborns
The initiative seeks to improve treatment and care of infants and children who were exposed to opioids in the womb.
Release: Astrocytes regulate signal speeds of neurons
NIH findings in rodents suggest that astrocytes play an important role in how the brain processes information.
Science Update: Researchers identify two cell types that produce melatonin in pineal gland
The brain’s pineal gland has two kinds of pinealocytes—cells that make melatonin—the hormone that regulates the body’s sleep and wake cycles, according to a rodent study conducted by researchers at the National Institutes of Health. The findings have the potential to inform future research on disorders that involve melatonin, such as jet lag and seasonal affective disorder.
Spotlight: Highlighting Research on Attention Deficit/Hyperactivity Disorder
NICHD’s mission includes understanding child development and behavior. Check out these scientific advances related to Attention Deficit/Hyperactivity Disorder.
Release: Neurons absorb and release water when firing, NIH study suggests
Neurons absorb and release water when they relay messages throughout the brain, according to a study by researchers at the National Institutes of Health and other institutions. Tracking this water movement with imaging technology may one day provide valuable information on normal brain activity, as well as how injury or disease affect brain function.